We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis to Assist Bayer in U.S. Validation of Betaseron Facility
Novartis to Assist Bayer in U.S. Validation of Betaseron Facility
March 27, 2007
As part of a legal settlement, Novartis will assist Bayer Schering Pharma in obtaining FDA validation of Bayer’s outsourced European Betaseron manufacturing facility, Bayer told DID March 27.